Tilray Medical Relaunches Cannabis Oral Solution Across Ireland With Reimbursement Approval
Canadian cannabis giant, Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY), has successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland under the country’s Medical Cannabis Access Program (MCAP).
